Screener
Sarepta Therapeutics, Inc. SRPT Other Reconciling Items
Other Reconciling Items at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept srpt:OtherReconcilingItems.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Income tax expense (benefit) | 3,141 | (43,254) | 15,356 | 20,736 |
| Depreciation and amortization expense | 10,409 | 10,840 | 21,003 | 20,818 |
| Stock-based compensation expense | 24,472 | 37,025 | 53,871 | 78,453 |
| Litigation contingency charge | 39,000 | — | 39,000 | — |
| Segment net (loss) income | $(4,890) | $196,892 | $326,069 | $(250,616) |
| Reconciliation of profit or loss | ||||
| Adjustments and reconciling items | — | — | — | — |
| Consolidated net (loss) income | $(4,890) | $196,892 | $326,069 | $(250,616) |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s other reconciling items?
- Sarepta Therapeutics, Inc. (SRPT) reported other reconciling items of $0 in Q2 2026.
- What does other reconciling items mean?
- Other Reconciling Items as reported by Sarepta Therapeutics,, Inc. Common Stock.
Ask your AI about Sarepta Therapeutics, Inc.'s other reconciling items.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude